Regional Analysis
Global Companion Animal Arthritis Market- Regional Insights
- North America is expected to be the largest market for companion animal arthritis during the forecast period, accounting for over 35.7% of the market share in 2023. In North America, the medication subsegment accounts for the largest share within the treatment segment for companion animal arthritis. Medication has historically been the most preferred treatment option due to the abundant availability of over-the-counter and prescription pain medications specifically formulated for pets. According to a report published by the American Animal Hospital Association, over 75% of arthritis cases in dogs and cats are primarily managed through different types of medication. Oral medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) have been the mainstay of treatment owing to their effectiveness in relieving pain and inflammation associated with the condition. Some of the most commonly prescribed NSAIDs include carprofen, deracoxib, firocoxib, meloxicam, and piroxicam. These are available as chewable tablets and liquids to make it easier for pet owners to administer them regularly.
- Asia Pacific market is expected to be the second-largest market for companion animal arthritis, accounting for over 25.2% of the market share in 2023. In terms of indication, the osteoarthritis subsegment contributes the highest share in the companion animal arthritis market in APAC owing to the prevalence of the condition among aging pets in the region. Osteoarthritis is the most common type of arthritis affecting dogs and cats over 6 years of age according to data from the World Small Animal Veterinary Association (WSAVA). APAC has a large and growing elderly companion animal population due to rising pet ownership and increasing life expectancy of pets over the last decade. Countries such as China, Japan, Australia, and New Zealand have seen the highest increase in the percentage of dogs and cats above 7 years of age. Older animals are more prone to developing osteoarthritis as the cartilage in their joints slowly degenerates with age.
- Europe market is expected to be the fastest-growing market for companion animal arthritis, with a share of 19% during the forecast period. In terms of animal type, dogs contribute the highest share to the companion animal arthritis market in Europe. As per data from the European Pet Food Industry Federation, there are over 100 million pet dogs owned across Europe. Dogs are especially prone to developing arthritis as they age due to their body weight and joint stress from activity. Many European dog owners consider their dogs as family members and prioritize their health needs. Some key factors contributing to dogs being the leading subsegment include their rising average lifespans and the growing popularity of large and giant dog breeds that are at higher risk for arthritis. As per data from the Swedish Board of Agriculture, the average lifespan of dogs in Sweden has increased from 11-12 years in the 1990s to over 13 years currently. Longer lifespans mean higher chances of age-related conditions like arthritis developing in a dog's lifetime. Additionally, dog breeds like Labradors, German Shepherds and Rottweilers very common across Europe and are categorized as heavy or giant breeds weighing over 25-30 kg, which puts more pressure on their joints as they grow older.
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East
U.S.: 
U.K. : 
India : 
